CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

Clinical trial NCT03029338 · COMPLETED

Trial details

NCT number: NCT03029338
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphomas Non-Hodgkin's B-Cell Relapse

Start date: 2017-06-08
Primary completion: 2019-05-22
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.